Document
IPR2023-00478, No. 1003 Exhibit - Ex 1003 Declaration Of Sylvia D Hall Ellis, PhD (P.T.A.B. Feb. 3, 2023)
Cite Document
IPR2023-00478, No. 1003 Exhibit - Ex 1003 Declaration Of Sylvia D Hall Ellis, PhD (P.T.A.B. Feb. 3, 2023)
+ More Snippets
Document
IPR2023-00478, No. 1029 Exhibit - Ex 1029 Erica K Evans, et al (P.T.A.B. Feb. 3, 2023)
Cite Document
IPR2023-00478, No. 1029 Exhibit - Ex 1029 Erica K Evans, et al (P.T.A.B. Feb. 3, 2023)
+ More Snippets
Document
IPR2023-00478, No. 1023-3 Exhibit - Ex 1023 Prosecution History of US Patent No 9,758,524 Part 3 (P.T.A.B. Feb. 3, 2023)
Cite Document
IPR2023-00478, No. 1023-3 Exhibit - Ex 1023 Prosecution History of US Patent No 9,758,524 Part 3 (P.T.A.B. Feb. 3, 2023)
+ More Snippets
Document
IPR2023-00478, No. 1010 Exhibit - Ex 1010 John C Byrd, et al (P.T.A.B. Feb. 3, 2023)
Cite Document
IPR2023-00478, No. 1010 Exhibit - Ex 1010 John C Byrd, et al (P.T.A.B. Feb. 3, 2023)
+ More Snippets
Document
IPR2023-00478, No. 1012 Exhibit - Ex 1012 US Provisional Application No 61974,665 (P.T.A.B. Feb. 3, 2023)
Cite Document
IPR2023-00478, No. 1012 Exhibit - Ex 1012 US Provisional Application No 61974,665 (P.T.A.B. Feb. 3, 2023)
+ More Snippets
Document
IPR2023-00478, No. 1027 Exhibit - Ex 1027 US Food and Drug Administration, Guidance for Industry (P.T.A.B. Feb. 3, 2023)
Cite Document
IPR2023-00478, No. 1027 Exhibit - Ex 1027 US Food and Drug Administration, Guidance for Industry (P.T.A.B. Feb. 3, 2023)
+ More Snippets
Document
IPR2023-00478, No. 1005 Exhibit - Ex 1005 US Patent No 9,758,524 to Barf, et al (P.T.A.B. Feb. 3, 2023)
Cite Document
IPR2023-00478, No. 1005 Exhibit - Ex 1005 US Patent No 9,758,524 to Barf, et al (P.T.A.B. Feb. 3, 2023)
+ More Snippets
Document
IPR2023-00478, No. 1008 Exhibit - Ex 1008 Bruce D Cheson, et al (P.T.A.B. Feb. 3, 2023)
Cite Document
IPR2023-00478, No. 1008 Exhibit - Ex 1008 Bruce D Cheson, et al (P.T.A.B. Feb. 3, 2023)
+ More Snippets
Document
IPR2023-00478, No. 1019 Exhibit - Ex 1019 Claire V Hutchinson, et al (P.T.A.B. Feb. 3, 2023)
Cite Document
IPR2023-00478, No. 1019 Exhibit - Ex 1019 Claire V Hutchinson, et al (P.T.A.B. Feb. 3, 2023)
+ More Snippets
Document
IPR2023-00478, No. 1028 Exhibit - Ex 1028 US Food and Drug Administration, Guidance for Industry MSSD (P.T.A.B. Feb. 3, 2023)
Cite Document
IPR2023-00478, No. 1028 Exhibit - Ex 1028 US Food and Drug Administration, Guidance for Industry MSSD (P.T.A.B. Feb. 3, 2023)
+ More Snippets
Document
IPR2023-00478, No. 1018 Exhibit - Ex 1018 Akintunde Akinleye, et al (P.T.A.B. Feb. 3, 2023)
Cite Document
IPR2023-00478, No. 1018 Exhibit - Ex 1018 Akintunde Akinleye, et al (P.T.A.B. Feb. 3, 2023)
+ More Snippets
Document
IPR2023-00478, No. 1040 Exhibit - Ex 1040 JAKAFI™ ruxolitinib Prescribing Information (P.T.A.B. Feb. 3, 2023)
Cite Document
IPR2023-00478, No. 1040 Exhibit - Ex 1040 JAKAFI™ ruxolitinib Prescribing Information (P.T.A.B. Feb. 3, 2023)
+ More Snippets
Document
IPR2023-00478, No. 1043 Exhibit - Ex 1043 Yan Bao, et al (P.T.A.B. Feb. 3, 2023)
Cite Document
IPR2023-00478, No. 1043 Exhibit - Ex 1043 Yan Bao, et al (P.T.A.B. Feb. 3, 2023)
+ More Snippets
Document
IPR2023-00478, No. 1004-2 Exhibit - Ex 1004 Prosecution History of US Patent No 10,272,083 Part 2 (P.T.A.B. Feb. 3, 2023)
Cite Document
IPR2023-00478, No. 1004-2 Exhibit - Ex 1004 Prosecution History of US Patent No 10,272,083 Part 2 (P.T.A.B. Feb. 3, 2023)
+ More Snippets
Document
IPR2023-00478, No. 1015 Exhibit - Ex 1015 M Dreyling, et al (P.T.A.B. Feb. 3, 2023)
Cite Document
IPR2023-00478, No. 1015 Exhibit - Ex 1015 M Dreyling, et al (P.T.A.B. Feb. 3, 2023)
+ More Snippets